Somanetics shares switch to Nasdaq National Market

By Angela McDaniels

Seattle, Feb. 6 - Somanetics Corp. said Nasdaq has approved the company's application to move its listing from the Nasdaq Capital Market to the Nasdaq National Market.

Somanetics' common shares will begin trading on the Nasdaq National Market on Tuesday under its current symbol, "SMTS."

Troy, Mich.-based Somanetics develops, manufactures and markets the Inovs System, a non-invasive patient monitoring system that measures changes in blood oxygen levels in the brain.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.